NINJ1 Aggravates Doxorubicin-Induced Cardiotoxicity by Suppressing AMPK-Mediated HIF-1α Deubiquitination
Antioxidants & Redox Signaling · 01.10.2026 · 45 (10-12) · 435-455
DOI: 10.1177/15230864261462524 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antioxidants & Redox Signaling, online erschienen am 22.06.2026. Verfasst von Yankun Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, the Second Affiliated Hospital of Chongqing Medical University, Chongqing, RP China. Hauptthemen laut MEDLINE: Doxorubicin, Hypoxia-Inducible Factor 1, alpha Subunit, Cardiotoxicity, AMP-Activated Protein Kinases. Die Arbeit nennt 67 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Aims
Doxorubicin (DOX) remains a cornerstone of cancer therapy but is limited by dose-dependent cardiotoxicity with inadequate protective strategies. Nerve injury-induced protein 1 (NINJ1), a regulator of inflammation and cell death, has not been explored in this context. We sought to define the role of NINJ1 in DOX-induced cardiotoxicity and evaluate its translational potential.
Results
Using complementary genetic, pharmacologic, and transcriptomic approaches, we demonstrate that NINJ1 is markedly upregulated in DOX-treated murine hearts and cardiomyocytes. Cardiomyocyte-specific NINJ1 deletion confers robust protection against cardiac dysfunction, oxidative stress, and apoptosis, whereas NINJ1 overexpression exacerbates injury. Mechanistically, NINJ1 suppresses AMP-activated protein kinase (AMPK) activation, promoting ubiquitin-mediated degradation of hypoxia-inducible factor-1α (HIF-1α), thereby impairing antioxidant gene programs. Multilevel evidence, including RNA sequencing, pathway enrichment, and gain- and loss-of-function models, establishes the NINJ1-AMPK-HIF-1α axis as a central regulator of redox homeostasis. Pharmacologic inhibition of NINJ1 with phenyl-β-D-glucopyranoside attenuates cardiac injury in vivo and in vitro without compromising DOX antitumor efficacy, supporting pathway specificity and therapeutic feasibility. Innovation: This study identifies NINJ1 as a previously unrecognized driver of anthracycline cardiotoxicity and uncovers a novel signaling axis linking membrane injury signaling to metabolic control of HIF-1α stability.
Conclusions
NINJ1 promotes DOX-induced cardiotoxicity by destabilizing HIF-1α via AMPK inhibition. Targeting NINJ1 represents a promising cardioprotective strategy. Clinical Significance: Therapeutic inhibition of NINJ1 protects the heart while preserving anticancer efficacy, offering a potential strategy to enhance the safety of anthracycline-based chemotherapy and improve outcomes in cancer patients. Antioxid. Redox Signal. 45, 435–455.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, the Second Affiliated Hospital of Chongqing Medical University, Chongqing, RP China.
- Cardiovascular Neuromodulation Research and Treatment Center, Chongqing, RP China.
ORCID-Profile: Zhiyu Ling
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Chen, Y., Yang, D., Chen, Y., Jiang, X., Zeng, Y., Xiao, P., & Ling, Z. (2026). NINJ1 Aggravates Doxorubicin-Induced Cardiotoxicity by Suppressing AMPK-Mediated HIF-1α Deubiquitination. Antioxidants & Redox Signaling, 45(10-12), 435-455. https://doi.org/10.1177/15230864261462524
Vancouver
Chen Y, Yang D, Chen Y, Jiang X, Zeng Y, Xiao P, et al. NINJ1 Aggravates Doxorubicin-Induced Cardiotoxicity by Suppressing AMPK-Mediated HIF-1α Deubiquitination. Antioxidants & Redox Signaling. 2026;45(10-12):435-455. doi:10.1177/15230864261462524
BibTeX
@article{Chen2026,
author = {Chen, Yankun and Yang, Dan and Chen, Yanghao and Jiang, Xi and Zeng, Yalin and Xiao, Peilin and Ling, Zhiyu},
title = {NINJ1 Aggravates Doxorubicin-Induced Cardiotoxicity by Suppressing AMPK-Mediated HIF-1α Deubiquitination},
journal = {Antioxidants & Redox Signaling},
year = {2026},
volume = {45},
number = {10-12},
pages = {435--455},
doi = {10.1177/15230864261462524}
}
EUVIMED